Riskpilot← Back to searchSign inGet full accessRØSTAD LEGESENTER AS
ASActiveOrg 913824091Helge Ingstads Veg 1, 7600 LevangerGeneral medical practice activities · NACE 8621Est. 20148 employees
Revenue 2024
NOK 12,5M
+16% vs 2023
EBITDA margin
2.6%
-2% vs 2023
Equity ratio
31.4%
Financial strength
Net profit 2024
NOK 121K
-26% vs 2023
| Revenue | NOK 12,5M | +16% |
| EBITDA | NOK 323K | -2% |
| Net profit | NOK 121K | -26% |
| Total assets | NOK 2,6M | -5% |
| Equity | NOK 818K | +17% |
| Employees | 8 | — |
Legal name
RØSTAD LEGESENTER AS
Org number
913824091
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. juni 2014
Share capital
NOK 44 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å drive legesenter og alt som står i forbindelse med dette, løsøre og verdipapirer, samt ved aksjer og parter å delta i andre selskaper og virksomheter.
Address
Helge Ingstads Veg 1, 7600 Levanger
Phone
+4774085050
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 888 | 9 560 | 9 813 | 10 821 | 12 547 |
| Staff expenses | −3 441 | −3 840 | −3 616 | −3 963 | −4 155 |
| EBITDA | 407 | 119 | 136 | 330 | 323 |
| Depreciation & amort. | −373 | −99 | −94 | −113 | −165 |
| EBIT | 35 | 20 | 41 | 217 | 158 |
| Net financials | −29 | −19 | −15 | −8 | −2 |
| Profit before tax | 6 | 1 | 27 | 209 | 156 |
| Tax | 1 | 0 | 6 | 46 | 35 |
| Net profit | 4 | 1 | 21 | 163 | 121 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 574 | 2 645 | 2 382 | 2 741 | 2 602 |
| Equity | 304 | 409 | 429 | 697 | 818 |
| Long-term debt | 658 | 440 | 215 | 0 | 0 |
| Short-term debt | 2 612 | 1 796 | 1 738 | 2 044 | 1 784 |
| Total debt | 3 270 | 2 236 | 1 953 | 2 044 | 1 784 |
EBITDA margin
2.6%
This company
15.8%
Market median
-84% vs market
20202024
Equity ratio
31.4%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20202024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20202024
Asset turnover
4.82×
This company
1.12×
Market median
+330% vs market
20202024
Debt / equity
2.18×
This company
0.62×
Market median
-252% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 10% | 10% | 2022 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Company | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Company | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 | |
| Individual | 9.09% | 9.09% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RØSTAD LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|